Introduction
The ischaemic penumbra represents the main target for acute stroke therapy (Muir et al., 2006) , and preventing it from progressing to infarction enhances neurological recovery (Furlan et al., 1996; Heiss et al., 1998) . Reperfusion therapies, namely intravenous thrombolysis and mechanical thrombectomy, are now licensed to salvage the penumbra, which has revolutionized stroke management. In spite of these breakthroughs, however, functional outcome remains poor (i.e. lost independence) in the majority of treated patients, even despite the 480% recanalization rate afforded by thrombectomy (Emberson et al., 2014; Goyal et al., 2016) . There is therefore an urgent need to identify novel therapeutic targets so as to improve functional recovery in successfully recanalized stroke patients (Fisher and Saver, 2015) .
In animal models the salvaged penumbra is consistently affected by selective neuronal loss (SNL) and resident microglia activation (for review see Baron et al., 2014) , and even isolated SNL at least transiently impacts sensorimotor performance (Sicard et al., 2006b; Balkaya et al., 2013; Ejaz et al., 2015) . Thus, SNL may hinder recovery by restricting neuronal plasticity in peri-infarct tissue, an area considered critical for recovery of lost functions (Cao et al., 1999; Cramer et al., 2000; Calautti and Baron, 2003; Jaillard et al., 2005; Nudo, 2006) . Accordingly, SNL may represent a novel therapeutic target for stroke. However, as it may exacerbate SNL via release of neurotoxic cytokines, microglia activation might in fact represent the prime therapeutic target (Kaushal and Schlichter, 2008; Kriz and Lalancette-Hebert, 2009; Hu et al., 2012; Baron et al., 2014) . This notion is supported by the finding in rodents of significant correlations between SNL and microglia activation in the surviving penumbra (Hughes et al., 2010 (Hughes et al., , 2012 . However, causality could just as well go in reverse given that microglia activation is initially triggered by neuronal death (Schwartz, 2003; Kriz and Lalancette-Hebert, 2009 ). Alternatively, therefore, SNL could result from other mechanisms, such as delayed ischaemic and/or reperfusion-related early neuronal death.
At this point, however, the key issue with respect to clinical relevance is whether the surviving penumbra is also affected by SNL and microglia activation in man, and if so, whether these two processes are correlated, which would point to microglia activation as primary target. To address these issues, and eventually identify target populations for drug trials, sensitive and selective imaging markers are required. Owing to the normality of conventional structural MRI in areas affected by SNL and microglia activation in rodents (Li et al., 1999; Sicard et al., 2006a; Wegener et al., 2006; Ejaz et al., 2013 Ejaz et al., , 2015 , radiolabelled tracers have been used so far. Prominent among these are the PET ligands 11 C-flumazenil (FMZ) and 11 C-[R]-PK11195 (PK), respectively, both recently validated in rodent models as selective in vivo markers against postmortem immunohistochemistry (Hughes et al., 2012; Ejaz et al., 2013) , confirming earlier in vitro studies showing colocalization of 3 H-labelled PK and FMZ with activated microglia and SNL, respectively (Myers et al., 1991; Stephenson et al., 1995; Katchanov et al., 2003) .
Few clinical stroke studies have so far investigated these issues. Although an FMZ-PET study documented the presence of SNL in the non-infarcted middle cerebral artery (MCA) territory, it did not assess the surviving penumbra directly per se (Guadagno et al., 2008) . Two other studies using 123 I-iomazenil (IMZ) single-photon emission tomography (SPECT) suggested the presence of SNL in the noninfarcted penumbra (Nakagawara et al., 1997; Saur et al., 2006) , but have limitations. The tracer IMZ is suboptimal because of slow tissue kinetics making its uptake and subsequent binding dependent on perfusion (Videbaek et al., 1993 (Videbaek et al., , 1995 , and furthermore, in one study, IMZ brain uptake was measured at an early post-injection time point (Saur et al., 2006) , likely exaggerating this perfusion dependence. The poor spatial resolution of SPECT may cause the low IMZ uptake present in infarcted areas to contaminate peri-infarct areas, in turn overestimating SNL. Also, in one study (Saur et al., 2006) , SPECT was performed 5-15 days post-stroke, when blood-brain barrier disruption is at its peak, while in the other the IMZ images were not coregistered with follow-up structural images (Nakagawara et al., 1997) , preventing direct assessment of IMZ uptake in the surviving penumbra. A recent small scale (n = 7 patients) FMZ-PET study, also from our group, which assessed FMZ binding in relation to functional MRI activation clusters, reported a significant FMZ binding reduction in the non-activated part, but not the activated part, of the surviving penumbra (Carrera et al., 2013) . Finally, a recent study using sophisticated cortex flattening methodology found reduced FMZ binding in the immediate peri-infarct area (Funck et al., 2017) , but the relevance of this finding to the penumbra is unclear as acute-stage perfusion mapping was not part of this study. Overall, therefore, although there is strong evidence of SNL in the non-infarcted MCA territory, whether it affects the surviving penumbra per se remains unsettled.
Even fewer clinical studies have thus far assessed microglial activation in non-infarcted tissue following MCA stroke, and none specifically the surviving penumbra. Two studies using PK-PET documented inflammation along the degenerating cortico-spinal tract (Radlinska et al., 2009; Thiel et al., 2010) , and another (Pappata et al., 2000) in the ipsilateral thalamus, which the authors attributed to Wallerian and/or retrograde thalamo-cortical degeneration as readily observed in rodents Tamura et al., 1991; Rupalla et al., 1998; Arlicot et al., 2010; Walberer et al., 2014) . In a study of six patients in whom PK-PET was performed 3-14 days post-stroke (Gerhard et al., 2005) , microglial activation was found in the non-infarcted ipsilateral hemisphere in four. However, as no measures were taken to control for the smearing of high within-infarct PK uptake onto neighbouring areas, the validity of these findings is uncertain. Like in the abovementioned studies, these authors also documented microglia activation in connected areas of the ipsilateral hemisphere and thalamus and pons bilaterally, again attributing it to remote degeneration. In a small-scale study from our group where immediate peri-infarct areas were excluded from the analysis by applying infarct mask dilatation (Price et al., 2006) , microglia activation was found in the non-infarcted affected MCA territory in three patients. Taken together, there is preliminary evidence for the presence of microglia activation in the non-infarcted MCA territory; however, no study so far has assessed microglia activation within the surviving penumbra per se.
We therefore designed the present mechanistic study to address two main unanswered questions: (i) is the non-infarcted penumbra affected by SNL and microglia activation in man? and (ii) does a quantitative correlation exist between these two processes? Based on the above evidence, we predicted the answer to both questions would be positive.
To test these hypotheses, we prospectively enrolled a sizeable sample of acute MCA stroke patients with documented penumbra on admission CT perfusion as well as early neurological improvement as a marker of penumbral salvage, to undergo both PK and FMZ PET in the subacute/early chronic stage, and follow-up MRI to map the final infarct.
Material and methods

Subjects
The Cambridgeshire Research Ethics Committee and the UK Administration of Radioactive Substances Advisory Committee approved this study. Written informed consent to participate was obtained from all subjects.
Patients
We prospectively recruited adult subjects (i) admitted within 6 h of onset (or last-time-seen-well) of first-ever MCA stroke; (ii) with admission National Institute of Health Stroke Scale (NIHSS) 52 (or isolated aphasia); (iii) in whom admission CT perfusion documented the presence of penumbra; and (iv) who experienced early neurological improvement, defined as a gain in NIHSS score 5 8 within the first 24 h or NIHSS 4 2 at 24 h (Saver, 2011), suggesting penumbral salvage. Eligible candidates were approached for consent only after routine 24 h NIHSS assessment and post-processing of the admission CT perfusion data had provided evidence of early neurological improvement and penumbra, respectively. Assessment of recanalization, which is not part of routine stroke management, did not belong in the study's imaging protocol. Exclusion criteria are listed in the Supplementary material.
Clinical assessment
Standard clinical data (age, gender, baseline observations, past medical history, vascular risk factors, drug and alcohol history, medications on admission and discharge, acute interventions for stroke administered and cause of stroke) were recorded for each recruited patient. Clinical course was determined by serial NIHSS measurements obtained on admission, at 24 h and at each follow-up PET visit.
Age-matched healthy controls
To obtain normative values, stroke-age healthy volunteers were recruited and underwent either the FMZ or the PK scan [12 and 10 subjects, of gender (female/male) and mean AE standard deviation (SD) 6/6 and 3/7, and 61 AE 8 and 60 AE 7 years, respectively]. Exclusion criteria are described in the Supplementary material.
CT perfusion
As part of standard clinical care, non-contrast CT (NCCT) and CT perfusion were acquired in immediate succession during the hyper-acute phase, in the same orientation. See Supplementary material for scanning procedures.
PET
Patients underwent both PK and FMZ PET, respectively in the subacute (Days 13-28, counting stroke day as Day 0) and early chronic (6-21 weeks) post-stroke stage. For PK this time window relied on previous studies showing it to be optimal for post-stroke microglia activation (Sette et al., 1993; Gerhard et al., 2005; Price et al., 2006) . For FMZ it was chosen to allow post-stroke SNL to become established (Nakagawara et al., 1997; Guadagno et al., 2008) . Note that SNL, once established, is stable (Sette et al., 1993; Nakagawara et al., 1997) , whereas post-stroke microglia activation is transient (Ramsay et al., 1992; Sette et al., 1993; Price et al., 2006) . Details on PET scanning procedures are provided in the Supplementary material.
MRI
Scans were performed immediately prior to or after each PET scanning session. Details on sequences used can be found in the Supplementary material.
Image processing and data analysis CT perfusion
The procedures, including the identification of penumbral voxels, followed those previously published in detail by our group (Guadagno et al., 2008; Alawneh et al., 2011; Carrera et al., 2013) , and are presented in the Supplementary material.
Infarct map and PET-MRI co-registration
The final infarct was manually outlined on the FLAIR images (with help from inspection of corresponding T 1 images whenever judged useful) by an experienced neurologist and imaging scientist (J.C.B.) blinded to the clinical data (see Fig. 1 for an illustration). PET-MRI co-registration was carried out as detailed previously (Guadagno et al., 2008; Alawneh et al., 2011; Carrera et al., 2013) . Further information is available in the Supplementary material.
PET
Binding potential (BP ND ) maps were generated voxel-wise for both FMZ and PK, using the basis function version of the simplified tissue reference model (STRM) (Lammertsma and Hume, 1996; Gunn et al., 1997) in Receptor Parametric Mapping (RPM) software, which controls for tracer entry in brain tissue. See the Supplementary material for further details.
Mapping selective neuronal loss and microglia activation within the ultimately non-infarcted middle cererbral artery territory Note that CT perfusion data were not used for this analysis.
FMZ: voxel-based single-subject analysis
We aimed to map and count, in each patient relative to the group of normal controls, the voxels with significantly reduced FMZ BP ND present within the affected-side MCA territory but outside the final infarct, as well as within the mirror mask in the unaffected hemisphere. This was accomplished by applying a single-subject voxel-wise analysis, which followed the methodology originally published by Signorini et al. (1999) and detailed in Guadagno et al. (2008) and in the Supplementary material.
PK: voxel-based single-subject analysis
The individual-subject SPM analysis implemented for FMZ was not applicable to the PK data because PK BP ND values, expressed relative to the cerebellum, are close to zero in normal brain tissue, with negative as well as positive values. We therefore applied the method previously used in Price et al. (2006) and detailed in the Supplementary material.
To increase sample size, two of the four patients previously reported by Price et al. (2006) , whose PK study was within the same time-window as the present study (Patients 1 and 2 of their Table 1 ; PK studies carried out on Days 13 and 25 post-stroke, respectively) were included in the present analysis. Apart from not undergoing a CT perfusion on admission, and therefore being ineligible for the subsequent analyses regarding the non-infarcted penumbra, these two patients were similar to the rest in terms of admission NIHSS and 24 h recovery (Table 2) .
Mapping selective neuronal loss and microglia activation within the non-infarcted penumbra
For this analysis, all three imaging modalities, namely PET, MRI and acute-stage CT perfusion, were used in conjunction and co-registration. Image processing details are provided in the Supplementary material. Given the 'pixellated' nature of the non-infarcted penumbra mask and the required cross-modalities image co-registration to native PET space, the voxel-based analysis described above for Tables 3 and 4 for individual FMZ and PK BP ND values in the non-infarcted MCA territory and non-infarcted penumbra in this patient. Consistent with these visual observations, this patient had the second lowest FMZ (affected/unaffected) ratio and highest (affected À unaffected) PK difference in the non-infarcted penumbra.
the non-infarcted MCA masks was not applicable. Instead, the FMZ and PK BP ND values across all voxels belonging in the non-infarcted penumbra and mirror non-infarcted penumbra masks were extracted in each subject, and compared across patients for statistical significance. For completeness, mean FMZ and PK BP ND values were also obtained for the non-penumbral part of the non-infarcted MCA mask, and for its mirror region (Supplementary material).
Relationship between selective neuronal loss and microglia activation
The relationship between SNL and microglia activation was determined by correlation analyses, first within the n/a n/a n/a 25.3 18 c n/a 13 1 25 n/a n/a n/a 2.7
Data are derived from the 16 patients recruited into the present study (Patients 1-16) and the two additional PK patients from Price et al. (2006) . n/a = not available/not applicable. Total infarct volume across the whole brain, obtained at FMZ session whenever applicable, otherwise at PK session (see the 'Materials and methods' section). non-infarcted MCA territory (both across the sample and individually), and then within the non-infarcted penumbra proper across the sample. See Supplementary material for details.
Statistical analysis
To test the hypothesis that SNL (or microglia activation) is present in the non-infarcted MCA territory, we assessed across the sample whether the number of FMZ (or PK) BP ND voxels within the non-infarcted MCA mask that survived the statistical threshold determined in the healthy controls was significantly higher than the corresponding voxel number in the mirror mask, as described elsewhere (Price et al., 2006; Guadagno et al., 2008) . To test this difference, non-parametric Wilcoxon signed-rank tests were used given the intrinsic zero-voxel floor effect (i.e. no surviving voxel) intrinsically skewing the distribution, and the wide distribution of actual voxel numbers exposing to the risk of outliers (Table 3) . Comparing the two hemispheres aimed to account for potential non-specific, bilaterally distributed changes in binding sites in the stroke population studied, either pre-morbid or secondary to stroke-related diffuse effects such as Wallerian degeneration (Gerhard et al., 2005; Guadagno et al., 2008) . To investigate whether age, time from onset to PET data acquisition or final infarct volume influenced the results, non-parametric correlation between the interhemispheric difference in significant voxel numbers and these potential confounders were also assessed.
To test the hypothesis that significant SNL affects the noninfarcted penumbra, we assessed whether, across patients, the individual mean FMZ BP ND values within the non-infarcted penumbra mask was significantly higher than that in the mirror mask, again using non-parametric Wilcoxon signedrank tests given the small sample and the risk of outliers. The same procedure was repeated for PK BP ND values, and for the non-penumbral counterpart regions. Two-tailed P 5 0.05 was regarded as significant throughout.
Results
Patients
Of 29 eligible patients, 10 declined to volunteer for the study and 19 consented. One patient subsequently withdrew consent, and PET studies failed in another two, leaving a total of 16 patients effectively included. In the same period, 229 patients underwent CT perfusion in our centre as potential candidates for thrombolysis, of whom 152 had a final diagnosis of anterior circulation stroke.
The main demographics and clinical data of the 16 included patients are presented in Table 1 . There were nine males and seven females, median age was 66 years and median admission NIHSS was 12 (range 3-21). Twelve patients were thrombolysed, and none thrombectomized. Table 2 shows the NIHSS scores at admission, 24 h n/a n/a n/a 15 345 0 345 n/a n/a n/a 16 n/a n/a n/a 2.46 1.17 1.29 a 17 n/a n/a n/a 4.45 2.86 1.59 a 18 n/a n/a n/a 1.01 0.42 0.59 a Data are derived from each of the 16 patients included in the present study plus the two PK patients from Price et al. (2006) . See 'Materials and methods' section for details and 'Results' section for statistical findings.
a Value higher than the upper 95% confidence limit for the interhemispheric difference in PK ratio derived from the 10 control subjects who underwent a PK PET study (value = 0.35%).
and time of the PET scans, as well as the stroke-to-PET delays and infarct volume.
PET scanning
Fifteen patients successfully underwent FMZ-PET, 14 PK-PET and 13 had both scans (Table 2 ). Both scans were not performed in three patients because of failed PK synthesis within the prescribed time-window (n = 2) and withdrawal from the study after FMZ-PET (n = 1; this patient, however, agreed to let us use her PK dataset).
Selective neuronal loss and microglia activation in the non-infarcted middle cerebral artery territory
FMZ
Of 15 patients, seven showed a greater number of voxels surviving the cut-off in the affected than unaffected hemisphere (often markedly so), two had mildly higher voxel number in the unaffected hemisphere, and six had no significant voxels in either hemisphere (Table 3 ). This distribution was statistically significant in favour of the affected hemisphere (Wilcoxon signed-rank test, z = À2.073, P = 0.039, r = 0.60; number of significant voxels: median affected = 101 versus median unaffected = 0). Figure 2 illustrates typical SPM findings across several brain slices in the same patient as shown in Fig. 1 , depicting the expected 'patchy' pattern of significant FMZ binding loss across the non-infarcted cortical MCA territory. See Supplementary material for further results.
PK
The PK ratio was larger in the affected than unaffected hemisphere in 12/16 patients (Table 3) , and across patients significantly increased on the affected hemisphere compared to the unaffected (median = 2.2% versus 1.5%; P = 0.021, Wilcoxon signed-rank test). In addition, the (affected À unaffected) interhemispheric PK ratio difference was significantly larger in patients as compared to the 10 controls (median = 5.5 and 0.08%, respectively; P = 0.008, Mann-Whitney test). Individually, the (affected À unaffected) difference in PK ratio was beyond the upper 95% confidence limit for interhemispheric difference derived from the 10 controls in 11/16 patients (Table 3) .
FMZ-PK relationship within the non-infarcted middle cerebral artery mask
There was no significant correlation between interhemispheric (affected À unaffected) difference in number of FMZ and PK significant voxels (tau = À0.128, P = 0.56). In the within-subject analysis, the correlation between FMZ BP ND affected/unaffected ratio and PK BP ND (affected À unaffected) difference did not reach statistical significance in any patient (n = 13).
Selective neuronal loss and microglia activation within the non-infarcted penumbra Table 4 shows for each subject the mean FMZ and PK BP ND values in the non-infarcted penumbra and mirror non-infarcted penumbra masks, the mean FMZ affected/unaffected ratio and the mean PK (affected À unaffected) difference.
FMZ
All 15 subjects who underwent an FMZ study had a lower mean FMZ BP ND in the non-infarcted penumbra compared to the mirror non-infarcted penumbra, a statistically significant distribution (median non-infarcted penumbra = 2.76 and 3.15, respectively; Wilcoxon signed-rank test, z = À3.408, P = 0.001). Conversely, there was no significant difference in mean FMZ BP ND in the non-penumbral portion of the Figure 2 Illustrative SPM readouts from Patient 2. Note this is the same patient as in Fig. 1 . Typical clusters of significant FMZ binding reduction projected onto five axial cuts from a normal T 1 -MRI template for anatomical orientation (as compared to 12 healthy controls, see 'Materials and methods' section) scattered across the right MCA territory cortical ribbon (yellow areas), i.e. ipsilateral to the stroke, with only few similar clusters on the left cortical ribbon (blue areas; see 'Materials and methods' section for an explanation as to how and why such clusters were identified in the unaffected hemisphere). Quantitative FMZ data for this patient are shown in Table 3 .
non-infarcted MCA mask as compared to its mirror region (P = 0.528, Wilcoxon signed rank test).
PK
Although nine of 14 patients had a higher mean PK BP ND in the non-infarcted penumbra compared to the mirror non-infarcted penumbra (median = À0.0926 versus À0.115, respectively), across the sample this difference did not reach statistical significance (Wilcoxon signedrank test, z = 1.35, P = 0.177). Conversely, mean PK BP ND was significantly higher in the non-penumbral portion of the non-infarcted MCA mask as compared to its mirror region (P = 0.004, Wilcoxon signed rank test).
Despite this negative finding across patients, visual inspection of the individual image datasets suggested the presence of increased PK binding within cortical noninfarcted penumbra in three patients (Patients 2, 9 and 16). Figure 1 illustrates for a single axial plane from Patient 2 the presence of increased PK binding in the cortical non-infarcted penumbra (yellow arrows), associated with reduced FMZ binding (red arrows). Accordingly, this patient had the highest (affected À unaffected) PK difference in the non-infarcted penumbra, along with the second lowest FMZ (affected/unaffected) ratio (Table 4 ). The (affected À unaffected) PK difference in the other two patients was, however, unremarkable. Note that comparing these values to normative data was not feasible, as mimicking the non-infarcted penumbra mask in the control subjects was deemed impossible, or far too inaccurate.
Relationship between selective neuronal loss and microglia activation within the non-infarcted penumbra Across the 13 patients, there was no significant relationship between mean FMZ BP ND affected/unaffected ratio and mean PK BP ND (affected À unaffected) difference within the non-infarcted penumbra (Kendall's tau = À0.154, P = 0.464) (Fig. 3) .
Discussion
This prospective study is the first to assess, in the same subjects, both SNL and microglia activation and their inter-relationships in the non-infarcted brain ipsilateral to MCA stroke. Consistent with but expanding from earlier reports, FMZ binding was significantly reduced and PK binding significantly increased in the whole non-infarcted MCA territory, for the first time documenting the co-occurrence of microglia activation and SNL beyond the infarct. The focus of this study was, however, the salvaged penumbra per se. Consistent with our hypothesis, FMZ binding was highly significantly reduced, directly documenting the presence of SNL in the salvaged penumbra in man. Importantly, none of these novel findings could be ascribed to partial volume effects, given the stringent dilated infarct mask approach implemented. Finally, contrary to our hypothesis, only mild and non-significant increases in PK binding were found in the salvaged penumbra across the sample-although it appeared to be present in n/a n/a n/a 96.6 15 3.369 4.023 0.838 n/a n/a n/a 24.6 16 n/a n/a n/a À0.099 À0.117 0.018 48.9
Data are derived from the 16 patients recruited in the present study. Also shown is the volume of non-infarcted penumbra, assessed in two CT perfusion slices. See 'Materials and methods' section for details and 'Results' section for statistical findings. n/a = not available.
one patient taken individually. Finally, there was no significant relationship between FMZ and PK binding changes either in the whole non-infarcted MCA territory or in the salvaged penumbra. Before addressing the mechanistic implications of these findings, some methodological points deserve comment. First, to identify the penumbra, we applied validated CT perfusion thresholds (Wintermark et al., 2006; Murphy et al., 2008) , as previously implemented by us (Alawneh et al., 2011; Carrera et al., 2013) . There is currently no consensus on which CT perfusion thresholds to be applied universally (Dani et al., 2011; Leigh et al., 2017) , and to date numerous CT perfusion thresholds based on different perfusion variables have been validated, though all in single or dual studies only (Wintermark et al., 2006; Murphy et al., 2008; Lin et al., 2014; McVerry et al., 2014; Copen et al., 2015; Cereda et al., 2016; Mokin et al., 2017) . Furthermore, to identify the penumbra, both penumbral and core perfusion thresholds must be applied, yet the latter are by definition time-dependent (Jones et al., 1981; Baron, 2001) , as recently confirmed in stroke patients (d'Esterre et al., 2015; Bivard et al., 2017) . Applying the same CT perfusion thresholds as those used here previously yielded biologically meaningful and expected results, particularly regarding clinical correlations (Alawneh et al., 2011) . Furthermore, tissue compartment volumes derived from the various validated thresholds are closely inter-related, and their relationships with clinical or tissue outcome appear stable across thresholds (Christensen et al., 2009; Bivard et al., 2011; Lin et al., 2016) . Accordingly, changing the thresholds in sensitivity analyses in our previous study did not affect the overall results (Alawneh et al., 2011) . As a matter of fact, the three main CT perfusion variables not only derive from the same contrast agent concentration time course, but are also mathematically inter-related (i.e. mean transit time = cerebral blood flow/cerebral blood volume), so that different thresholds capture widely overlapping voxel subsets. Second, only two CT perfusion slabs were available, so any microglia activation present in cranial-and caudalmost axial sections would have been missed. Third, we used the specific PET ligands FMZ and PK to investigate SNL and microglia activation, respectively. As FMZ binds selectively to the neuron-specific GABA A receptor, we were unable to investigate the white matter component of the salvaged penumbra, may have missed SNL affecting non-GABA A neuronal populations and, due to locally low GABA A -receptor density, were unable to investigate striatal SNL, which is commonly seen after brief proximal MCA occlusion in rodents (Fujioka et al., 2003; Katchanov et al., 2003; Baron et al., 2014; Brunner et al., 2017) . As a result, we may have underestimated the extent/magnitude of SNL. Regarding PK, it almost exclusively reflects microglia activation (Ejaz et al., 2016) so our findings essentially do not reflect other components of post-stroke inflammation such as astrocytosis and infiltration by blood-borne neutrophils and monocytes. Although PK and FMZ have been formally validated in rodent stroke models as in vivo markers of microglia activation and SNL, respectively (see 'Introduction' section), direct validation of their intended pathological substrates in humans is available for 3 H-labelled PK only . Fourth, although sizeable, our sample was relatively small. However, (i) our FMZ and PK samples taken separately were both larger than any previous similar study (see 'Introduction' section); (ii) significant FMZ reductions and PK increases were clearly demonstrated despite the relatively small samples; and (iii) no previous clinical stroke study has involved both FMZ and PK PET. More generally, assembling a sample of stroke patients with documented acute penumbra, marked early recovery and willingness to undergo two ligand PET studies represents a major achievement-not to mention successfully completing such complex investigations. However, our findings apply only to patients fulfilling these criteria, and may not generalize to the entire stroke population. That said, our sample does reflect current candidates for thrombolysis and bridging therapy.
Although well-established in rodent models (for a review see Baron et al., 2014) , this study is the first to formally document the existence of SNL in the surviving penumbra in man. The only previous similar study that used FMZ in affected/unaffected (A/U) side ratio and PK (affectedunaffected; A-U) side difference for the non-infarcted penumbra. For details see the 'Materials and methods' section. This plot shows no clear relationship between the two variables, which was confirmed by the statistical analysis (Kendall's tau = À0.154, P = 0.464). Note that Kendall's rank correlation corrects for any potential outlier. Note also the data point at the bottom right corner of the sample, i.e. with highest PK value and the second lowest FMZ value in the non-infarcted penumbra, corresponds to Patient 2, in whom visual inspection of the image dataset suggested the presence of increased PK binding in the non-infarcted penumbra (Fig. 1). conjunction with acute perfusion imaging documented SNL in the non-infarcted MCA territory but did not directly assess the non-infarcted penumbra (Guadagno et al., 2008) . Another small-scale FMZ-PET study (Carrera et al., 2013) provided only indirect support to the presence of SNL in the non-infarcted penumbra. Two SPECT studies suggested the presence of SNL in the non-infarcted penumbra (Nakagawara et al., 1997; Saur et al., 2006) but had significant methodological limitations (see 'Introduction' section for details).
In our previous study (Guadagno et al., 2008 ) the hypothesis that SNL affects the non-infarcted penumbra was indirectly tested by assessing the relationship between FMZ binding and acute-stage perfusion across regions of interest sampling the affected hemisphere, which revealed the predicted significant negative relationship. Here, in contrast, it was feasible to co-register the PET, MRI and acute-stage CT perfusion datasets, which allowed us to directly document reduced FMZ in the non-infarcted penumbra. In a post hoc analysis applying Guadagno et al.'s (2008) methodology onto the present material, no significant relationship between FMZ and perfusion was found either within or across subjects (data not shown). This negative finding may be explained firstly because the present sample had less extensive acute hypoperfusion than in Guadagno et al. (2008) , reducing the chance of finding a relationship, and secondly because in the latter study the correlations, when significant, had very shallow slopes. Applying the same methodology to the PK dataset, a significant positive PK-perfusion correlation (i.e. in the expected direction) was present in 3/13 patients, but a negative slope was found in five patients, and the mean slope did not differ from zero. This negative finding is consistent with the observed lack of significant microglia activation in the non-infarcted penumbra, while the presence of microglia activation in the whole non-infarcted MCA mask likely reflects secondary degeneration (see below), whose link with acute hypoperfusion would not be expected.
That the salvaged penumbra can be affected by SNL has potential clinical implications. First, although undetectable on standard MRI (yet possibly identifiable on very-high-field scanners), SNL may contribute to post-stroke neurological impairment over and above that resulting from the infarct per se. Second, SNL may also affect the potential for reorganization and plasticity in the salvaged penumbra, and in turn hinder recovery. Although in rats, isolated SNL is associated with sometimes prolonged behavioural impairment (Sicard et al., 2006b; Balkaya et al., 2013; Ejaz et al., 2015) , only indirect evidence for such an effect exists in man (see 'Introduction' section). To test whether SNL impacted recovery (i.e. FMZ-study minus admission NIHSS) in the present study, we added SNL severity to our previously validated linear model including salvaged penumbra and extra-penumbral infarct extension (Alawneh et al., 2011; Tisserand et al., 2014) , which, however, failed because 11/16 patients had 100% recovery (Table 2) . Using non-parametric partial correlations to at least partly account for this ceiling effect, salvaged penumbra volume had the expected positive effect on NIHSS recovery, but not SNL (data not shown). However, this ceiling effect prevented the proper testing of this hypothesis. Given the NIHSS only includes major neurological impairments, simple validated assessments of manual dexterity (Calautti et al., 2007) and left-and right-sided MCA stroke-related cognitive deficits (Hillis et al., 2002) were prospectively part of this study's protocol. However, it proved practically impossible to administer them in the hyperacute stroke setting, and eventually these data were available in too few patients for meaningful analysis. These issues notwithstanding, preventing SNL as an adjunct to reperfusion therapies might facilitate and even perhaps enhance ultimate post-stroke recovery.
Our second main hypothesis was that the non-infarcted penumbra would also be affected by microglia activation in man. Contrary to this hypothesis, however, our data for the noninfarcted penumbra showed only mild and non-significant PK BP ND increases. Rather than a sample size issue, this negative finding might reflect the stringent dilated infarct mask methodology implemented, which, as per our previous study (Price et al., 2006) , was necessary because partial volume effects may cause spill-out of the high PK binding present in necrotic tissue-reflecting massive macrophage-led phagocytosis-onto neighbouring cortex (Fig. 1) . Note, however, that there is currently no alternative to PET to assess microglia activation in vivo. Although we cannot formally exclude the presence of microglia activation in the immediate peri-infarct rim, this is a small region that in addition includes the periinfarct inflammatory scar (Moskowitz et al., 2010) , which has no clear clinical relevance. In addition, despite using the same methodology, we did detect the presence of SNL in the noninfarcted penumbra, as predicted, with high statistical significance. Our hypothesis was based on consistent observations in rodents of marked microglia activation in the salvaged penumbra, as biologically expected in close topographical congruence with SNL (Katchanov et al., 2003; Hughes et al., 2010; Ejaz et al., 2013 Ejaz et al., , 2015 . Given this topographical congruence and the fact that previous clinical FMZ-PET studies have shown cortical SNL to adopt a widely distributed patchy pattern (Guadagno et al., 2008; Carrera et al., 2013) , as also found here (Fig. 2) , one might expect microglia activation to be detectable just as easily as SNL was. Could our negative finding therefore relate to another feature of our study, namely the timing of PK-PET, 13-28 days post-stroke? Time course studies in rodents have consistently shown prominent microglia activation in the stroke hemisphere from Day 3 up to Day 28, peaking around Day 7-14, and only slightly declining by Day 28 (Benavides et al., 1990; Cremer et al., 1992; Fukumoto et al., 2011; Lartey et al., 2014; Walberer et al., 2014; Martin et al., 2015) . In baboons, PK binding in the peri-infarct region showed a slightly slower time course, peaking between Days 20-30 (Sette et al., 1993) . Acknowledging the complexities involved in carrying out longitudinal PET studies in stroke patients, the available studies suggest a time course similar to that in baboons (Ramsay et al., 1992; Gerhard et al., 2000; Price et al., 2006) . It is therefore unlikely that the peak of microglia activation was missed in the present study. Taken together, therefore, our study provides strong evidence that microglia activation is not present to any significant amounts in the non-infarcted penumbra in man. Interestingly, however, visual inspection of the individual image datasets suggested it was perhaps present in three patients, and more conspicuously in one (Fig. 1) . This suggests that although on average microglia activation does not significantly affect the non-infarcted penumbra in man, it may be occasionally encountered.
Consistent with this overall mismatch between SNL and microglia activation in the non-infarcted penumbra, there was not even a trend for a correlation between them in this tissue compartment (Fig. 3) . This negative finding conflicts with our rodent study revealing a significant correlation between SNL and microglia activation, assessed post-mortem at Day 14 post-stroke (Hughes et al., 2010) , reflecting the abovementioned topographical congruence between these two processes. It is unlikely this discrepancy resulted from the exclusion of the immediate peri-infarct tissue here, since in man, similar to rodents (Sicard et al., 2006b; Hughes et al., 2010; Ejaz et al., 2013) , cortical SNL is patchy and widely distributed throughout the MCA territory (see above). A species difference might therefore exist.
In turn, our findings provide evidence that microglia activation is unlikely to contribute to any significant degree to the SNL involving the non-infarcted penumbra. Although microglia activation is initially triggered by ischaemic neuronal injury (Moskowitz et al., 2010) , the mismatch and lack of correlation between these two processes found here suggest no lingering relationship between them in man. Our study's clinical implication is therefore that interventions aimed at mitigating microglia activation may not prevent penumbral SNL in man-or at the very least that trials testing this approach should screen for the occasional patients with imaging evidence of both microglia activation and SNL affecting the non-infarcted penumbra. Other mechanisms for SNL should therefore be considered. Prominent among them is ischaemia-triggered neuronal damage (Guadagno et al., 2008) , which if true could be prevented by improving penumbral perfusion or oxygenation until reperfusion is achieved (Shuaib et al., 2011; Ejaz et al., 2016; Poli et al., 2017; Savitz et al., 2017) . Another potential mechanism for scattered cortical neuronal death is capillary obstruction-so-called no-reflow-seemingly caused by pericyte contraction in severely ischaemic areas (Yemisci et al., 2009; Dalkara and Arsava, 2012) .
Using optimized methodology, the present study confirmed the presence of microglia activation in the non-infarcted MCA territory, previously suggested by two small-scale studies (Gerhard et al., 2005; Price et al., 2006 ) (see 'Introduction' section). More precisely, our data indicate highly significant microglia activation presence within the non-penumbral part of the non-infarcted MCA territory, in sharp contrast with microglia activation absence in its penumbral part, while the opposite contrast was true for FMZ. This topographical non-congruence, with SNL preferentially affecting the rescued cortical penumbra while microglia activation affects other tissue components, in turn explains the observed lack of correlation between FMZ and PK changes in the non-infarcted penumbra. As detailed in the 'Introduction' section, several clinical studies previously documented microglia activation as a marker of remote degeneration after stroke, particularly involving white matter tracts (Pappata et al., 2000; Gerhard et al., 2005; Radlinska et al., 2009; Thiel et al., 2010) . It is likely the presence of microglia activation in the non-penumbral part of the non-infarcted MCA territory here reflects similar processes. Whether such remote degeneration is clinically relevant or represents an epiphenomenon is unclear. Some rodent studies suggest that blocking remote inflammation may reduce secondary damage in connected thalamic or brainstem nuclei (for review see Zhang et al., 2012) , with potential behavioural benefits, but others conversely suggest that post-stroke microglia activation has pro-repair effects and that its pharmacological blockade may worsen behavioural outcome (LalancetteHebert et al., 2007; Moskowitz et al., 2010; Szalay et al., 2016; Jin et al., 2017) . Although this dichotomy and time course are hotly debated (Ransohoff, 2016) , neurotoxic effects are thought to predominate in the first week and prorepair effects later on (Hu et al., 2012) .
Conclusion
The present mechanistic dual-tracer PET study in a sizeable sample of MCA territory stroke patients establishes the presence of microglial activation in the non-infarcted MCA territory taken as a whole, uncorrelated with neuronal loss. More important, we demonstrate for the first time the presence of patchy SNL affecting the magnetic resonance normal-appearing cortical ribbon within the surviving penumbra. The lack of associated microglial activation suggests the latter may not contribute to SNL in human stroke. In turn, the presence of microglia activation in non-infarcted areas probably represents remote degenerative processes rather than potentially neurotoxic inflammation further damaging the penumbra. The main clinical implications from our findings are, first, that the documented presence of SNL affecting the salvaged penumbra may hinder neuronal plasticity and functional recovery, and as such may represent a novel therapeutic target as an adjunct to reperfusion therapies; and, second, that microglial activation may not stand as primary target for interventions aiming to prevent SNL. Other interventions, such as improving penumbral perfusion/oxygenation before reperfusion is achieved and/or preventing capillary obstruction, may more efficiently prevent SNL. For such trials, FMZ-PET may be of use to monitor treatment effects.
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